RAPS: FDA Guidance Aims to Clarify Development of Medical Countermeasures
28.08.2014
A new final guidance document issued by the US Food and Drug Administration (FDA) aims to make it easier to develop in vitro diagnostic devices (IVDs) intended to act as microbiological or medical countermeasures.
SciencePharma
